Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-11-051957
Filing Date
2011-10-18
Accepted
2011-10-18 16:35:24
Documents
1
Period of Report
2011-10-12

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c23435_3x0.html 3  
1 MAIN DOCUMENT DESCRIPTION c23435_3x0.xml 3 1536
  Complete submission text file 0001209191-11-051957.txt   3036
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., STE 505 SAN FRANCISCO CA 94080
Business Address
Rubin Marc (Reporting) CIK: 0001412377 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31791 | Film No.: 111146062